Dr. Joseph Khoury, MD

• Hematology

• Anatomic & Clinical Pathology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• American University Of Beirut Faculty Of Medicine

  Medical School, 1997

• Chronic Lymphocytic Leukemia Progression Diagnosis with Intrinsic Cellular Patterns via Unsupervised Clustering, 2022-05-13

• Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm, 2022-07-11

• BRAFKinase Domain Mutations are Common inRASwtChronic Myelomonocytic Leukemia, 2014-02-10

• Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma, 2019-02-12

• Potential Biomarkers for Treatment Response to the BCL-2 Inhibitor Venetoclax: State of the Art and Future Directions, 2021-06-14

• Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens, 2018-10-19

• 3q26.2/MECOMRearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features, 2023-01-11

• First Report of a Phase II Prospective Study of Combination of Hyper-CVAD with Ponatinib in Frontline Therapy of Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia, 2015-09-30

• Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma, 2016-07-19

• T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes, 2021-01-19

• Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma involving the Mesentery with Volumetric Image Guided Intensity Modulated Radiation Therapy, 2018-09-10

• Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells, 2019-01-15

• The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype,TP53Deletion, and a Poor Prognosis, 2021-12-16

• PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm, 2019-05-19

• Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update, 2022-07-17

• Cytogenetic Risk Stratification of 417 Patients with Chronic Myelomonocytic Leukemia from a Single Institution, 2014-05-16

• Unusual case of human herpesvirus 8-positive large B-cell lymphoma associated with Castleman disease, 2019-02-07

• Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative ALL, 2016-08-10

• A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma, 2019-08-05

• Crystal-Storing Histiocytosis: A Clinicopathologic Study of 13 Cases, 2015-08-27

• Mutually exclusive recurrentKRASandMAP2K1mutations in Rosai-Dorfman disease, 2017-06-30

• The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms, 2022-06-22

• Artificial Intelligence and Digital Microscopy Applications in Diagnostic Hematopathology, 2020-03-26

• Colonic myeloid sarcoma with mutatedNPM1manifesting with ulceration, 2022-02-08

• Clinicopathological characterization of chronic lymphocytic leukemia withMYD88mutations: L265P and non-L265P mutations are associated with different features, 2020-08-26

• Acute Myeloid Leukemia withMYCRearrangement andJAK2V617F Mutation, 2015-06-25

• Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification, 2022-01-08

• Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists, 2016-08-08

• Pan-RAF Inhibition Shows Anti-Leukemic Activity inRAS-Mutant Acute Myeloid Leukemia Cells and Potentiates the Effect of Sorafenib in Cells withFLT3Mutation, 2020-11-25

• TP53Mutation Does Not Confer a Poor Outcome in Adult ALL Treated with Frontline Hyper-CVAD-based Regimens, 2017-06-13

• Discovery of imatinib-responsiveFIP1L1-PDGFRAmutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia, 2014-03-27

• Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia, 2022-02-07

• Simultaneous deletion of3'ETV6and5'EWSR1genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review, 2016-02-27

• Next-Generation Companion Diagnostics Promises, Challenges, and Solutions, 2016-08-16

• Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis, 2015-04-08

• A Single Case of Rosai-Dorfman Disease Marked by Pathologic Fractures, Kidney Failure, and Liver Cirrhosis Treated with Single-Agent Cladribine, 2014-10-29

• CellSpatialGraph: Integrate hierarchical phenotyping and graph modeling to characterize spatial architecture in tumor microenvironment on digital pathology, 2021-10-09

• Evolutionary action score identifies a subset ofTP53mutated myelodysplastic syndrome with favorable prognosis, 2021-03-06

• Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial, 2017-08-24

• Data onMECOMrearrangement-driven chromosomal aberrations in myeloid malignancies, 2019-05-23

• Artificial intelligence strategy integrating morphologic and architectural biomarkers provides robust diagnostic accuracy for disease progression in chronic lymphocytic leukemia, 2021-10-25

• Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution, 2018-11-02

• Development ofTP53Mutations Over the Course of Therapy for Acute Myeloid Leukemia, 2021-08-19

• CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management, 2021-10-26

• PPP1R7Is a Novel Translocation Partner ofCBFBvia t(2;16)(q37;q22) in Acute Myeloid Leukemia, 2022-07-29

• CD123 as a Biomarker in Hematolymphoid Malignancies: Principles of Detection and Targeted Therapies, 2020-10-23